1. Home
  2. BHR vs NKTR Comparison

BHR vs NKTR Comparison

Compare BHR & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHR
  • NKTR
  • Stock Information
  • Founded
  • BHR 2013
  • NKTR 1990
  • Country
  • BHR United States
  • NKTR United States
  • Employees
  • BHR N/A
  • NKTR N/A
  • Industry
  • BHR Real Estate Investment Trusts
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BHR Real Estate
  • NKTR Health Care
  • Exchange
  • BHR Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • BHR 222.2M
  • NKTR 247.9M
  • IPO Year
  • BHR N/A
  • NKTR 1994
  • Fundamental
  • Price
  • BHR $3.23
  • NKTR $0.94
  • Analyst Decision
  • BHR Hold
  • NKTR Buy
  • Analyst Count
  • BHR 1
  • NKTR 3
  • Target Price
  • BHR $2.50
  • NKTR $4.00
  • AVG Volume (30 Days)
  • BHR 175.1K
  • NKTR 2.2M
  • Earning Date
  • BHR 11-06-2024
  • NKTR 11-07-2024
  • Dividend Yield
  • BHR 6.21%
  • NKTR N/A
  • EPS Growth
  • BHR N/A
  • NKTR N/A
  • EPS
  • BHR N/A
  • NKTR N/A
  • Revenue
  • BHR $732,339,000.00
  • NKTR $93,137,000.00
  • Revenue This Year
  • BHR N/A
  • NKTR $12.85
  • Revenue Next Year
  • BHR N/A
  • NKTR N/A
  • P/E Ratio
  • BHR N/A
  • NKTR N/A
  • Revenue Growth
  • BHR N/A
  • NKTR 5.53
  • 52 Week Low
  • BHR $1.79
  • NKTR $0.46
  • 52 Week High
  • BHR $3.95
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • BHR 42.34
  • NKTR 41.05
  • Support Level
  • BHR $3.35
  • NKTR $0.99
  • Resistance Level
  • BHR $3.54
  • NKTR $1.05
  • Average True Range (ATR)
  • BHR 0.15
  • NKTR 0.06
  • MACD
  • BHR -0.04
  • NKTR 0.01
  • Stochastic Oscillator
  • BHR 6.36
  • NKTR 22.92

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and Renaissance, among others.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: